Exeter Financial LLC Boosts Stake in UnitedHealth Group Incorporated $UNH

Exeter Financial LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 41.4% during the second quarter, according to its most recent filing with the SEC. The firm owned 645 shares of the healthcare conglomerate’s stock after acquiring an additional 189 shares during the period. Exeter Financial LLC’s holdings in UnitedHealth Group were worth $201,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in UNH. Bayforest Capital Ltd grew its stake in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd grew its stake in shares of UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after buying an additional 50 shares during the last quarter. Copia Wealth Management purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $42,000. IAG Wealth Partners LLC purchased a new stake in UnitedHealth Group during the 1st quarter valued at $42,000. Finally, Kentucky Trust Co boosted its stake in UnitedHealth Group by 53.8% during the 2nd quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock valued at $45,000 after purchasing an additional 50 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

Several brokerages have commented on UNH. KeyCorp cut their target price on UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 30th. Sanford C. Bernstein increased their target price on UnitedHealth Group from $337.00 to $379.00 and gave the company an “outperform” rating in a research note on Friday, September 5th. Bank of America increased their target price on UnitedHealth Group from $290.00 to $325.00 and gave the company a “neutral” rating in a research note on Monday, August 18th. Royal Bank Of Canada lowered their price target on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Finally, Oppenheimer lowered their price target on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Sixteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $358.95.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $351.87 on Thursday. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The stock’s fifty day moving average is $298.81 and its 200 day moving average is $362.32. The stock has a market cap of $318.68 billion, a P/E ratio of 15.25, a P/E/G ratio of 2.27 and a beta of 0.45. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same period in the prior year, the business posted $6.80 earnings per share. UnitedHealth Group’s revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.